PR Newswire
CAMBRIDGE, Mass. , April 12, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler , Chief Executive Officer of Akebia, will present at the 20 th Annual Needham Virtual Healthcare Conference on Thursday, April 15 at 1:30 p.m. ET .
A live webcast of the presentation can be accessed through the Investors section of the Company's website at https://ir.akebia.com . A replay of the webcast will be available for approximately 30 days following the conference.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts . For more information, please visit our website at www.akebia.com , which does not form a part of this release.
Akebia Therapeutics Contact
Kristen K. Sheppard, Esq.
ir@akebia.com
SOURCE Akebia Therapeutics, Inc.